Clinical Trials Browser

Phase 2 × Pancreatic Adenocarcinoma × Erlotinib Hydrochloride × Clear all

NCT01389440 2018-05-18

GEMCAD1003

Phase 2 Completed

Gastrointestinal

Pancreatic Adenocarcinoma